Harbour Investment Management LLC Increases Holdings in Danaher Corporation (NYSE:DHR)

Harbour Investment Management LLC increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 1.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,952 shares of the conglomerate’s stock after purchasing an additional 135 shares during the quarter. Harbour Investment Management LLC’s holdings in Danaher were worth $2,249,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 99 shares during the period. Heck Capital Advisors LLC bought a new position in Danaher in the 4th quarter worth approximately $27,000. Sierra Ocean LLC raised its holdings in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher during the 1st quarter worth approximately $31,000. Finally, Rialto Wealth Management LLC purchased a new stake in shares of Danaher during the 4th quarter worth approximately $34,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president owned 15,179 shares of the company’s stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by corporate insiders.

Danaher Stock Performance

DHR stock opened at $203.08 on Monday. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The business’s fifty day simple moving average is $195.63 and its two-hundred day simple moving average is $207.10. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $281.70. The firm has a market cap of $145.33 billion, a price-to-earnings ratio of 39.43, a PEG ratio of 2.85 and a beta of 0.77.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.63%. Danaher’s payout ratio is 24.85%.

Analysts Set New Price Targets

Several analysts have recently issued reports on DHR shares. Evercore ISI decreased their price objective on Danaher from $240.00 to $230.00 and set an “outperform” rating on the stock in a report on Tuesday, April 22nd. Robert W. Baird decreased their price objective on Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Citigroup reaffirmed a “buy” rating on shares of Danaher in a report on Monday, April 7th. Bank of America decreased their price objective on Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Finally, Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a report on Friday, March 14th. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $248.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.